Cefprozil
Appearance
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | ORAL |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 95% |
Protein binding | 36% |
Elimination half-life | 1.3 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H19N3O5S |
Molar mass | 389.427 g/mol g·mol−1 |
3D model (JSmol) | |
|
Cefprozil, sometimes spelled cefproxil and sold under the brand name Cefzil, is a cephalosporin type antibiotic. In Europe, it is sold by the name Procef. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Although there is a widely quoted cross-allergy risk of 10% between cephalosporins and penicillin, an article in the Journal of Family Practice (February 2006)[1] has shown no increased risk for cross-allergy for cefprozil and several other 2nd generation or later cephalosporins.